| Factor Information | |
|---|---|
| Data ID | 2994 |
| Factor | inotropic support |
| Description | N/A |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | effect of neonatal transport on clinical markers of cardiovascular instability in CHD |
| p Value | 0.01 |
| Conclusion | A higher proportion of neonates in group I (SpO2<75%) received inotropes, in comparison with both other groups. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 646 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TGA/PA/PS/CoA/HLHS/other |
| Reference | |
|---|---|
| PMID | 19776649 |
| Year | 2008 |
| Title | Impact of Oxygen Saturation Targets and Oxygen Therapy during the Transport of Neonates with Clinically Suspected Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | patients' data | |
| Region | Toronto, Canada | |
| Method | univariate analysis(Pearson correlation) | |
| Race | Canadian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | group I neonates with SpO2<75%(Treatment) | group II neonates with SpO2 between 75%-85%(Control) |
| Number | 8 | 6 |
| Age | 39.3±1.0 gestational weeks | 37.6±2.9 gestational weeks(group II) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 8(57%)(number and proportion of neonates in group I (average SpO2<75% groups) | 6(16%) number and proportion of neonates in group II (average SpO2:75-85%% groups) |
